This site is intended for healthcare professionals only
LoginRegister
KKR divests 5.8 percent stake in JB Chemicals & Pharma for Rs 1460 croreCarlyle Group divests 4.3% stake in Indegene for Rs 636 crore
AstraZeneca Imfinzi based perioperative regimen recommended for approval in EU for resectable non-small cell lung cancerAstraZeneca Estimates Rs 35 Crore Tax Benefit After ITAT Remands Transfer Pricing Issues
US Tariffs May Pressure Indian Pharma, Threaten Biocon Revenues: FitchSix Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel
novavax to sell facility in BohumilNovavax to sell Bohumil manufacturing facility to Novo Nordisk for USD 200 million
Alembic Pharma bags USFDA tentative approval for Olopatadine Hydrochloride Ophthalmic Solution to treat itchy eyesAlembic Pharma bags USFDA tentative approval for Olopatadine Hydrochloride Ophthalmic Solution to...
FDA Grants Breakthrough Therapy Designation to Sacituzumab TirumotecanUSFDA grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan for Metastatic Nonsquamous...
Over 700 bottles of Codeine Cough Syrup seized, 2 arrestedAssam police dispose of 37000 bottles of contraband phensedyl cough syrup
Gilead Company Kite to buy Interius BioTherapeutics for USD 350 millionIntas Pharma to acquire Udenyca business from Coherus BioSciences
Gland Pharma bags USFDA nod for Cangrelor for InjectionGland Pharma Vice President (Strategy, Investments & Investor Relations) Ankit Gupta tenders...
Cipla Bommasandra facility gets VAI classification from USFDAPromoters Samina, Rumana Hamied exit Cipla by selling 1.72 percent stake
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataGlenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review
USFDA approves Tonix Pharma Tonmya for fibromyalgia in adultsUSFDA nod to Gland Pharma Latanoprost Ophthalmic Solution
X